Century Therapeutics, Inc. earnings per share and revenue

IPSC earnings per share for the last quarter are 0.89 USD whereas the estimation was -0.01 USD which accounts for 11530.77% surprise. Company revenue for the same period amounts to 109.16 M USD despite the estimated figure of 41.29 M USD. Estimated earnings per share for the next quarter are -0.35 USD, and revenue is expected to reach 3.43 M USD. Also watch annual changes over time to get a bigger picture of IPSC earnings per share and revenue dynamics.